Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
C08CA09
Source
AIFA
C08CA09(WHO)
In general: ℞ (Prescription only)
Diethyl 4-{o-[(E)-2-tert-butoxycarbonylethenyl]phenyl}-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
103890-78-4
5311217
4470736
260080034N
D04657Y
DTXSID1046429
Interactive image
CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2/C=C/C(=O)OC(C)(C)C)C(=O)OCC)C)C
InChI=1S/C26H33NO6/c1-8-31-24(29)21-16(3)27-17(4)22(25(30)32-9-2)23(21)19-13-11-10-12-18(19)14-15-20(28)33-26(5,6)7/h10-15,23,27H,8-9H2,1-7H3/b15-14+Key:GKQPCPXONLDCMU-CCEZHUSRSA-N
Lacidipine(tradenamesLacipilorMotens) is acalcium channel blocker. It is available as tablets containing 2 or 4 mg.
It was patented in 1984 and approved for medical use in 1991.
⚠️ Warnings
• Caution should be exercised in patients with history of heart, liver and kidney disease, blood disorder, allergic reactions, during pregnancy and breastfeeding.
• Do not drink grapefruit juice while taking this medication.